Successful treatment of a critical COVID-19 patient with tocilizumab

• Shih-Ming Tsao,
• Jann-Yuan Wang,
• Chien-Feng Li,
• Ming-Chang Hsieh,
• Yao-Tung Wang,
• Kuei-Chuan Chan,
• Hui-Hsien Pan,
• Yuan-Ti Lee,
• Yi-Wen Huang

Affiliations

Shih-Ming Tsao

School of Medicine and Technology, Chung Shan Medical University, Taichung, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Jann-Yuan Wang

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

Chien-Feng Li

School of Medicine and Technology, Chung Shan Medical University, Taichung, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Ming-Chang Hsieh

Medical Sciences and Technology, Chung Shan Medical University, Taichung, Taiwan; Laboratory Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Yao-Tung Wang

School of Medicine and Technology, Chung Shan Medical University, Taichung, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Kuei-Chuan Chan

School of Medicine and Technology, Chung Shan Medical University, Taichung, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Hui-Hsien Pan

School of Medicine and Technology, Chung Shan Medical University, Taichung, Taiwan; Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan

Yuan-Ti Lee

Corresponding author. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Department of Internal Medicine and Centre of Infection Control, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Rd., Taichung 40201, Taiwan. Fax: +886 4 23248135.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

Yi-Wen Huang

Corresponding author.; Pulmonary and Critical Care Unit, Chang-Hua Hospital Ministry of Health and Welfare, Chang-Hua, Taiwan